======= TRIM28 ======= == Gene Information == * **Official Symbol**: TRIM28 * **Official Name**: tripartite motif containing 28 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10155|10155]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q13263|Q13263]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TRIM28&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TRIM28|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601742|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene mediates transcriptional control by interaction with the Kruppel-associated box repression domain found in many transcription factors. The protein localizes to the nucleus and is thought to associate with specific chromatin regions. The protein is a member of the tripartite motif family. This tripartite motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Nuclear corepressor for KRAB domain-containing zinc finger proteins (KRAB-ZFPs). Mediates gene silencing by recruiting CHD3, a subunit of the nucleosome remodeling and deacetylation (NuRD) complex, and SETDB1 (which specifically methylates histone H3 at 'Lys-9' (H3K9me)) to the promoter regions of KRAB target genes. Enhances transcriptional repression by coordinating the increase in H3K9me, the decrease in histone H3 'Lys-9 and 'Lys-14' acetylation (H3K9ac and H3K14ac, respectively) and the disposition of HP1 proteins to silence gene expression. Recruitment of SETDB1 induces heterochromatinization. May play a role as a coactivator for CEBPB and NR3C1 in the transcriptional activation of ORM1. Also corepressor for ERBB4. Inhibits E2F1 activity by stimulating E2F1-HDAC1 complex formation and inhibiting E2F1 acetylation. May serve as a partial backup to prevent E2F1-mediated apoptosis in the absence of RB1. Important regulator of CDKN1A/p21(CIP1). Has E3 SUMO-protein ligase activity toward itself via its PHD-type zinc finger. Also specifically sumoylates IRF7, thereby inhibiting its transactivation activity. Ubiquitinates p53/TP53 leading to its proteosomal degradation; the function is enhanced by MAGEC2 and MAGEA2, and possibly MAGEA3 and MAGEA6. Mediates the nuclear localization of KOX1, ZNF268 and ZNF300 transcription factors. In association with isoform 2 of ZFP90, is required for the transcriptional repressor activity of FOXP3 and the suppressive function of regulatory T-cells (Treg) (PubMed:23543754). Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells (PubMed:24623306). Also required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs) (PubMed:24623306). Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing (PubMed:24623306). The SETDB1-TRIM28-ZNF274 complex may play a role in recruiting ATRX to the 3'-exons of zinc-finger coding genes with atypical chromatin signatures to establish or maintain/protect H3K9me3 at these transcriptionally active regions (PubMed:27029610). Acts as a corepressor for ZFP568 (By similarity). {ECO:0000250|UniProtKB:Q62318, ECO:0000269|PubMed:10347202, ECO:0000269|PubMed:11959841, ECO:0000269|PubMed:15882967, ECO:0000269|PubMed:16107876, ECO:0000269|PubMed:16862143, ECO:0000269|PubMed:17079232, ECO:0000269|PubMed:17178852, ECO:0000269|PubMed:17704056, ECO:0000269|PubMed:17942393, ECO:0000269|PubMed:18060868, ECO:0000269|PubMed:18082607, ECO:0000269|PubMed:20424263, ECO:0000269|PubMed:20858735, ECO:0000269|PubMed:20864041, ECO:0000269|PubMed:21940674, ECO:0000269|PubMed:23543754, ECO:0000269|PubMed:23665872, ECO:0000269|PubMed:24623306, ECO:0000269|PubMed:27029610, ECO:0000269|PubMed:8769649, ECO:0000269|PubMed:9016654}. |PHD| |zf-B box| |Krueppel-associated box domain binding| |negative regulation of DNA demethylation| |regulation of genetic imprinting| |chromo shadow domain binding| |convergent extension involved in axis elongation| |regulation of DNA demethylation| |changes to DNA methylation involved in embryo development| |DNA methylation involved in embryo development| |positive regulation of methylation-dependent chromatin silencing| |regulation of methylation-dependent chromatin silencing| |positive regulation of chromatin silencing| |convergent extension| |negative regulation of single stranded viral RNA replication via double stranded DNA intermediate| |negative regulation of viral release from host cell| |SUMO transferase activity| |regulation of single stranded viral RNA replication via double stranded DNA intermediate| |nuclear heterochromatin| |embryonic placenta morphogenesis| |axis elongation| |nuclear euchromatin| |regulation of viral release from host cell| |embryo implantation| |positive regulation of protein import into nucleus| |regulation of chromatin silencing| |positive regulation of protein import| |DNA methylation| |DNA alkylation| |promoter-specific chromatin binding| |regulation of protein import into nucleus| |positive regulation of DNA binding| |negative regulation of viral genome replication| |regulation of protein import| |positive regulation of nucleocytoplasmic transport| |DNA methylation or demethylation| |positive regulation of DNA repair| |protein sumoylation| |epithelial to mesenchymal transition| |RNA polymerase II transcription factor complex| |positive regulation of protein localization to nucleus| |negative regulation of viral life cycle| |embryonic placenta development| |DNA modification| |regulation of viral genome replication| |negative regulation of viral process| |positive regulation of response to DNA damage stimulus| |positive regulation of chromatin organization| |regulation of nucleocytoplasmic transport| |developmental growth involved in morphogenesis| |chromatin| |regulation of protein localization to nucleus| |negative regulation of DNA metabolic process| |regulation of DNA repair| |regulation of DNA binding| |regulation of gene silencing| |regulation of viral life cycle| |placenta development| |positive regulation of intracellular protein transport| |mesenchymal cell differentiation| |positive regulation of chromosome organization| |transcription initiation from RNA polymerase II promoter| |positive regulation of binding| |female pregnancy| |regulation of chromatin organization| |protein autophosphorylation| |positive regulation of DNA metabolic process| |regulation of viral process| |positive regulation of intracellular transport| |multi-multicellular organism process| |negative regulation of multi-organism process| |DNA-templated transcription, initiation| |regulation of response to DNA damage stimulus| |regulation of symbiosis, encompassing mutualism through parasitism| |mesenchyme development| |regulation of intracellular protein transport| |protein kinase activity| |transcription corepressor activity| |ubiquitin-protein transferase activity| |Ras protein signal transduction| |macromolecule methylation| |transcription coactivator activity| |ubiquitin protein ligase binding| |methylation| |peptidyl-lysine modification| |small GTPase mediated signal transduction| |negative regulation of locomotion| |positive regulation of cellular protein localization| |regulation of chromosome organization| |regulation of intracellular transport| |regulation of DNA metabolic process| |regulation of binding| |in utero embryonic development| |developmental growth| |growth| |chromatin binding| |sequence-specific DNA binding| |reproductive structure development| |positive regulation of protein transport| |reproductive system development| |morphogenesis of an epithelium| |embryonic organ development| |positive regulation of establishment of protein localization| |transcription by RNA polymerase II| |DNA repair| |protein complex oligomerization| |regulation of cellular protein localization| |tissue morphogenesis| |embryonic morphogenesis| |positive regulation of organelle organization| |chordate embryonic development| |transcription, DNA-templated| |nucleic acid-templated transcription| |embryo development ending in birth or egg hatching| |RNA biosynthetic process| |developmental process involved in reproduction| |protein ubiquitination| |chromatin organization| |viral process| |regulation of protein transport| |regulation of cellular response to stress| |regulation of peptide transport| |DNA metabolic process| |regulation of establishment of protein localization| |innate immune response| |protein modification by small protein conjugation| |cellular response to DNA damage stimulus| |regulation of multi-organism process| |symbiotic process| |interspecies interaction between organisms| |zinc ion binding| |negative regulation of transcription by RNA polymerase II| |peptidyl-amino acid modification| |regulation of cellular localization| |defense response to other organism| |protein phosphorylation| |embryo development| |regulation of locomotion| |protein modification by small protein conjugation or removal| |positive regulation of transport| |multi-organism reproductive process| |regulation of protein localization| |chromosome organization| |nucleobase-containing compound biosynthetic process| |epithelium development| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of transcription, DNA-templated| |positive regulation of cellular component organization| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |phosphorylation| |regulation of organelle organization| |response to other organism| |organic cyclic compound biosynthetic process| |response to external biotic stimulus| |response to biotic stimulus| |negative regulation of RNA metabolic process| |defense response| |negative regulation of cellular macromolecule biosynthetic process| |RNA binding| |reproductive process| |reproduction| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |regulation of response to stress| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |protein-containing complex assembly| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |intracellular signal transduction| |cellular response to stress| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |tissue development| |macromolecule biosynthetic process| |positive regulation of molecular function| |protein-containing complex subunit organization| |regulation of transport| |immune response| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|-2.05| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|-1.95| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|-1.71| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|1.79| |[[:results:exp459|Bleomycin 5μM R08 exp459]]|1.8| |[[:results:exp502|Milciclib 2μM R08 exp502]]|1.82| |[[:results:exp515|PU-H71 1μM R08 exp515]]|1.86| |[[:results:exp199|Etoposide 0.3μM R05 exp199]]|2.06| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|2.08| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|2.1| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|2.13| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|2.25| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|2.37| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|2.57| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|2.77| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|2.8| |[[:results:exp67|BVD-523 15μM R02 exp67]]|2.95| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|4.01| ^Gene^Correlation^ |[[:human genes:n:nsd1|NSD1]]|0.642| |[[:human genes:i:id3|ID3]]|0.602| |[[:human genes:d:dohh|DOHH]]|0.582| |[[:human genes:m:mllt1|MLLT1]]|0.573| |[[:human genes:z:znf592|ZNF592]]|0.563| |[[:human genes:r:rptor|RPTOR]]|0.561| |[[:human genes:b:bap1|BAP1]]|0.551| |[[:human genes:m:mtor|MTOR]]|0.539| |[[:human genes:m:mlst8|MLST8]]|0.534| |[[:human genes:m:med23|MED23]]|0.526| |[[:human genes:a:arl14ep|ARL14EP]]|0.521| |[[:human genes:b:brpf1|BRPF1]]|0.519| |[[:human genes:w:wdr24|WDR24]]|0.508| |[[:human genes:f:faf2|FAF2]]|0.506| |[[:human genes:i:irf2bp2|IRF2BP2]]|0.504| |[[:human genes:c:ccdc101|CCDC101]]|0.502| |[[:human genes:o:otud5|OTUD5]]|0.5| |[[:human genes:z:znf608|ZNF608]]|0.5| |[[:human genes:f:fbxo11|FBXO11]]|0.499| |[[:human genes:h:hars|HARS]]|0.497| |[[:human genes:h:hhex|HHEX]]|0.491| |[[:human genes:p:pfn1|PFN1]]|0.484| |[[:human genes:b:bak1|BAK1]]|0.482| |[[:human genes:u:ube2g2|UBE2G2]]|0.482| |[[:human genes:p:plaa|PLAA]]|0.482| |[[:human genes:s:setdb1|SETDB1]]|0.479| |[[:human genes:r:rnmt|RNMT]]|0.476| |[[:human genes:c:cbx3|CBX3]]|0.475| |[[:human genes:t:thg1l|THG1L]]|0.473| |[[:human genes:c:cmtr1|CMTR1]]|0.463| |[[:human genes:t:tle4|TLE4]]|0.461| |[[:human genes:v:vhl|VHL]]|0.446| |[[:human genes:d:dr1|DR1]]|0.444| |[[:human genes:x:xpo6|XPO6]]|0.444| |[[:human genes:a:atf7ip|ATF7IP]]|0.443| |[[:human genes:g:gfpt1|GFPT1]]|0.437| |[[:human genes:t:trip12|TRIP12]]|0.437| |[[:human genes:m:med25|MED25]]|0.434| |[[:human genes:z:znf445|ZNF445]]|0.434| |[[:human genes:e:exoc4|EXOC4]]|0.434| |[[:human genes:c:casp9|CASP9]]|0.429| |[[:human genes:p:ppp2r3c|PPP2R3C]]|0.429| |[[:human genes:n:nae1|NAE1]]|0.429| |[[:human genes:u:ubqln1|UBQLN1]]|0.426| |[[:human genes:p:pdpk1|PDPK1]]|0.426| |[[:human genes:c:cbfb|CBFB]]|0.426| |[[:human genes:p:pdap1|PDAP1]]|0.424| |[[:human genes:a:asxl2|ASXL2]]|0.424| |[[:human genes:p:pmm2|PMM2]]|0.423| |[[:human genes:s:serf2|SERF2]]|0.422| |[[:human genes:b:bptf|BPTF]]|0.421| |[[:human genes:m:meaf6|MEAF6]]|0.421| |[[:human genes:t:tti2|TTI2]]|0.42| |[[:human genes:u:uap1|UAP1]]|0.419| |[[:human genes:r:romo1|ROMO1]]|0.418| |[[:human genes:g:gmppb|GMPPB]]|0.418| |[[:human genes:t:triap1|TRIAP1]]|0.416| |[[:human genes:a:apaf1|APAF1]]|0.416| |[[:human genes:a:alg13|ALG13]]|0.416| |[[:human genes:u:usp22|USP22]]|0.415| |[[:human genes:p:ppp6c|PPP6C]]|0.415| |[[:human genes:t:taf4|TAF4]]|0.415| |[[:human genes:a:aars|AARS]]|0.415| |[[:human genes:s:scaf8|SCAF8]]|0.414| |[[:human genes:w:wdr59|WDR59]]|0.413| |[[:human genes:h:hccs|HCCS]]|0.412| |[[:human genes:d:ddx42|DDX42]]|0.412| |[[:human genes:a:asb7|ASB7]]|0.412| |[[:human genes:o:opa1|OPA1]]|0.409| |[[:human genes:g:gtf3c4|GTF3C4]]|0.407| |[[:human genes:v:vdac2|VDAC2]]|0.405| |[[:human genes:m:med16|MED16]]|0.405| |[[:human genes:p:prkrir|PRKRIR]]|0.401| |[[:human genes:d:dpagt1|DPAGT1]]|0.401| |[[:human genes:p:pum1|PUM1]]|0.4| Global Fraction of Cell Lines Where Essential: 1/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1852 * **Expression level (log2 read counts)**: 9.08 {{:chemogenomics:nalm6 dist.png?nolink |}}